The June 2016 edition of Dutch Quest magazine features a six-page article about bacteriophages. In the article “Vriend faag: virussen gaan ons beschermen tegen bacteriën“, Micreos’ CEO Mark Offerhaus explains how phages work and how Micreos is using this technology to tackle problems such as MRSA. The June edition will … Continue reading →

In the wake of the problems associated with increasing antimicrobial resistance, scientists have now developed the first effective alternative to antibiotics in a significant advance in the fight against drug-resistant infection. Here, Bjorn Herpers looks at the promise of endolysins. It is easy to become numb to stories we frequently … Continue reading →